Results for tag: "Human Parainfluenza Virus 3 Infection"

The Human Parainfluenza Virus 3 (HPIV3) Infection is a contagious respiratory illness caused by the HPIV3 virus. Symptoms of HPIV3 infection include fever, runny nose, sore throat, cough, and difficulty breathing. Treatment for HPIV3 infection typically involves antiviral medications, such as ribavirin and oseltamivir, as well as supportive care. Vaccines are available to help prevent HPIV3 infection. The HPIV3 Infection market is a subset of the larger Infectious Diseases Drugs market. This market is composed of pharmaceutical companies that develop and manufacture drugs to treat HPIV3 infection. These companies are typically involved in research and development, clinical trials, and marketing of their products. Some companies in the HPIV3 Infection market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Johnson & Johnson. Show Less Read more